Previous close | 24.00 |
Open | N/A |
Bid | 18.00 |
Ask | 21.95 |
Strike | 60.00 |
Expiry date | 2024-07-19 |
Day's range | 24.00 - 24.00 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Medtronic's (MDT) rapid cadence of new product approvals is a strong foundation for future growth. However, the company also navigates some macroeconomic challenges.
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and CompaniesLOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market, today announced that Medtronic plc (NYSE: MDT), a global leader in healthcare technology, has been selected as winner of the “Best New Mo
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2024 on Thursday, May 23, 2024. A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's fourth quarter and full fiscal year 2024, which ended on Friday, April 26, 2024.